Advertisement

Tumor Biology

, Volume 35, Issue 4, pp 3509–3515 | Cite as

The variant interleukin 1f7 rs3811047 G>A was associated with a decreased risk of gastric cardiac adenocarcinoma in a Chinese Han population

  • Xu Wang
  • Jun Yin
  • Liang Zheng
  • Liming Wang
  • Yijun Shi
  • Weifeng Tang
  • Guowen Ding
  • Chao Liu
  • Ruiping Liu
  • Suocheng Chen
  • Haiyong Gu
Research Article

Abstract

To investigate the association between gastric cardiac adenocarcinoma (GCA) and six functional single nucleotide polymorphisms (SNPs) including interleukin 1A (IL1A) rs1800587 C>T, IL1B rs16944 G>A, IL1f7 rs3811047 G>A, IL3 rs40401 C>T, IL3 rs2073506 G>A, and IL7Rα rs6897932 A>G. We performed a hospital-based case–control study to evaluate the genetic effects of these SNPs. A total of 243 GCA cases and 476 controls were enrolled in this study. A custom-by-design 48-Plex SNPscanTM kit was used to determine the genotypes. The IL1f7 rs3811047 G>A polymorphism was significantly associated with a decreased risk of GCA either in the single locus analyses or the recessive genetic model. However, there was no significant association between the other five SNPs and GCA risk. These results elucidated that the functional polymorphism, IL1f7 rs3811047 G>A, might contribute to GCA susceptibility. However, the statistical power of our study was limited, large well-designed studies and further functional investigations are needed to confirm our findings.

Keywords

IL1f7 Polymorphisms Gastric cardiac adenocarcinoma Molecular epidemiology 

Abbreviations

CI

Confidential interval

GCA

Gastric cardiac adenocarcinoma

IL7Rα

Interleukin 7 receptor alpha

OR

Odds ratio

SNPs

Single nucleotide polymorphisms

Notes

Acknowledgments

We wish to thank Dr. Da Ding and Dr. Yan Liu (Genesky Biotechnologies Inc., Shanghai, China) for technical support.

Grant support

This study was supported in part by National Natural Science Foundation of China (81370001, 81371927, 81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333, BK2011481), Social Development Foundation of Zhenjiang (SH2010017), Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102), Affiliated People’s Hospital of Jiangsu University fund (Y200913) and Jiangsu University Clinical medicine science and technology development fund (JLY20120004).

Condensed abstract

We performed a hospital-based case–control study to evaluate the genetic effects of six SNPs including interleukin 1A (IL1A) rs1800587 C>T, IL1B rs16944 G>A, IL1f7 rs3811047 G>A, IL3 rs40401 C>T, IL3 rs2073506 G>A, and IL7Rα rs6897932 A>G on the development of GCA. Our results demonstrated that functional variant IL1f7 rs3811047 G>A might contribute to GCA susceptibility.

Conflicts of interest

We declare that we have no conflicts of interest.

Reference

  1. 1.
    Zhang L, Du C, Guo X, Yuan L, Niu W, Yu W, et al. Interleukin-8-251a/t polymorphism and helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of china. Mol Biol Rep. 2010;37:3983–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Hu S, Song QB, Yao PF, et al. No relationship between il-1b gene polymorphism and gastric acid secretion in younger healthy volunteers. World J Gastroenterol. 2005;11:6549–53.PubMedGoogle Scholar
  3. 3.
    Zhang W, Li C, Wang J, He C. Functional polymorphisms in fas/fasl system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma. Hepatogastroenterology. 2012;59:141–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Hussain SP, Harris CC. Inflammation and cancer: An ancient link with novel potentials. Int J Cancer. 2007;121:2373–80.PubMedCrossRefGoogle Scholar
  5. 5.
    Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4:11–22.PubMedCrossRefGoogle Scholar
  6. 6.
    Lin WW, Karin MA. Cytokine-mediated link between innate immunity, inflammation and cancer. J Clin Invest. 2007;117:1175–83.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Smyth MJ, Cretney E, Kershaw MH, et al. Cytokines in cancer immunity and immunotherapy. Immunol Rev. 2004;202:275–93.PubMedCrossRefGoogle Scholar
  8. 8.
    Dominici R, Cattaneo M, Malferrari G, et al. Cloning and functional analysis of the allelic polymorphism in the transcription regulatory region of interleukin-1 alpha. Immunogenetics. 2002;54:82–6.PubMedCrossRefGoogle Scholar
  9. 9.
    Wen AQ, Wang J, Feng K, et al. Effects of haplotypes in the interleukin 1beta promoter on lipopolysaccharide-induced interleukin 1beta expression. Shock. 2006;26:25–30.PubMedCrossRefGoogle Scholar
  10. 10.
    Prasad KN, Nyati KK, Verma A, et al. Tumor necrosis factor-alpha polymorphisms and expression in guillain-barré syndrome. Hum Immunol. 2010;71:905–10.PubMedCrossRefGoogle Scholar
  11. 11.
    El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cance. Nature. 2000;404:398–402.PubMedCrossRefGoogle Scholar
  12. 12.
    Vincenzi B, Patti G, Galluzzo S, et al. Interleukin 1beta-511 t gene (il1beta) polymorphism is correlated with gastric cancer in the Caucasian population: results from a meta-analysis. Oncol Rep. 2008;20:1213–20.PubMedGoogle Scholar
  13. 13.
    Dinorah NMC, Elvira GG, Reyes BL, et al. Association of il1b–511c/-31 t haplotype and helicobacter pylori vaca genotypes with gastric ulcer and chronic gastritis. BMC Gastroenterol. 2010;10:126–34.CrossRefGoogle Scholar
  14. 14.
    Pan F, Liao F, Xia G, et al. Association of il-1f7 gene with suscepti-bility to human leukocyte antigen-b27 positive ankylosing spon-dylitis in Han Chinese population. Clin Chim Acta. 2010;411:124–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Pei B, Xu S, Liu T, et al. Associations of the il-1f7 gene polymorphisms with rheumatoid arthritis in Han Chinese population. Int J Immunogenet. 2012;40:199–203.PubMedCrossRefGoogle Scholar
  16. 16.
    Potvin S, Stip E, Sepehry AA, et al. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Slattery ML, Lundgreen A, Bondurant KL, et al. Interferon-signaling pathway: associations with colon and rectal cancer risk and subsequent survival. Carcinogenesis. 2011;32:1660–7.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Schweiger A, Stern D. Lohman IC, et a: Differences in proliferation of the hematopoietic cell line tf-1 and cytokine production by peripheral blood leukocytes induced by 2 naturally occurring forms of human il-3. J Allergy Clin Immunol. 2001;107:505–10.PubMedCrossRefGoogle Scholar
  19. 19.
    Booth DR, Arthur AT, Teutsch SM, et al. Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis. J Mol Med. 2005;83:822–30.PubMedCrossRefGoogle Scholar
  20. 20.
    Lundmark F, Duvefelt K, Lacobaeus E, et al. Variation in interleukin 7 receptor alpha chain (il7r) in fluences risk of multiple sclerosis. Nat Genet. 2007;39:1108–13.PubMedCrossRefGoogle Scholar
  21. 21.
    Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet. 2007;39:857–64.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Zheng L, Yin J, Wang L, Wang X, Shi Y, Shao A, et al. Interleukin 1b rs16944 G>A polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population. Clin Biochem. 2013;46:1469–73.PubMedCrossRefGoogle Scholar
  23. 23.
    Cheng J, Zhang H, Zhuang C, et al. Peptidylarginine deiminase type 4 and methyl-cpg binding domain 4 polymorphisms in Chinese patients with rheumatoid arthritis. J Rheumatol. 2012;39:1159–65.PubMedCrossRefGoogle Scholar
  24. 24.
    Kwon SJ. Evaluation of the 7th uicc tnm staging system of gastric cancer. J Gastric Cancer. 2011;11:78–85.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Gu H, Ding G, Zhang W, Liu C, Chen Y, Chen S, et al. Replication study of plce1 and c20orf54 polymorphism and risk of esophageal cancer in a Chinese population. Mol Biol Rep. 2012;39:9105–11.PubMedCrossRefGoogle Scholar
  26. 26.
    Wei J, Zheng L, Liu S, Yin J, Wang L, Wang X, et al. Mir-196a2 rs11614913 T>C polymorphism and risk of esophageal cancer in a Chinese population. Hum Immunol. 2013;74:1199–205.PubMedCrossRefGoogle Scholar
  27. 27.
    Banchereau J, Pascual V, O’Garra A, et al. From il-2 to il-37: the expanding spectrum of anti-inflammatory cytokines. Nat Immunol. 2012;13:925–31.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    McNamee EN, Masterson JC, Jedlicka P, et al. Interleukin 37 expression protects mice from colitis. Proc Natl Acad Sci U S A. 2011;108:16711–6.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Kumar S, Hanning CR, Brigham-Burke MR, et al. Interleukin-1f7b (il-1h4/il-1f7) is processed by caspase-1 and mature il-1f7b binds to the il-18 receptor but dose not induce ifn-gamma production. Cytokine. 2002;18:61–71.PubMedCrossRefGoogle Scholar
  30. 30.
    Pan G, Risser P, Mao W, et al. Il-1h, an interleukin 1-related protein that binds il-18 receptor/il-1rrp. Cytokine. 2001;13:1–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Gao W, Kumar S, Lotze MT, et al. Innate immunity mediated by the cytokine il-1 homologue 4 (il-1h4/il-1f7) induces il-12-dependent adaptive and profound antitumor immunity. J Immunol Rev. 2003;170:107–13.Google Scholar
  32. 32.
    Xue H, Lin B, Ni P, Xu H, Huang G. Interleukin-1b and interleukin-1 rn polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol. 2010;25:1604–17.PubMedCrossRefGoogle Scholar
  33. 33.
    Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, et al. Association of interleukin 1b gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut. 2003;52:1684–9.PubMedCentralPubMedCrossRefGoogle Scholar
  34. 34.
    Hou L, El-Omar EM, Chen J, Grillo P, Rabkin CS, Baccarelli A, et al. Polymorphisms in th1-type cell-mediated response genes and risk of gastric cancer. Carcinogenesis. 2007;28:118–23.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Xu Wang
    • 1
  • Jun Yin
    • 1
  • Liang Zheng
    • 2
  • Liming Wang
    • 3
  • Yijun Shi
    • 1
  • Weifeng Tang
    • 1
  • Guowen Ding
    • 1
  • Chao Liu
    • 1
  • Ruiping Liu
    • 4
  • Suocheng Chen
    • 1
  • Haiyong Gu
    • 1
    • 5
  1. 1.Department of Cardiothoracic SurgeryAffiliated People’s Hospital of Jiangsu UniversityZhenjiangChina
  2. 2.Department of Cardiothoracic SurgeryThe First People’s Hospital of Changzhou and The Third Affiliated Hospital of Suzhou UniversityChangzhouChina
  3. 3.Cancer institute, Department of chemotherapyPeople’s Hospital Affiliated to Jiangsu UniversityZhenjiangChina
  4. 4.Department of OrthopedicsAffiliated Hospital of Nanjing Medical University, Changzhou Second People’s HospitalChangzhouChina
  5. 5.Department of Cardiothoracic SurgeryAffiliated People’s Hospital of Jiangsu UniversityZhenjiangChina

Personalised recommendations